Corrigendum to "Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.".
Where this comes from
- Record sourced from PubMed, PMID 36120704.
- Also identified by DOI 10.1016/j.eclinm.2022.101636 and PMC identifier 9467817.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2021.101125.].